CFTR and obesity due to melanocortin 4 receptor deficiency: The advancements in gene therapy and the subsequent introduction of CFTR modulator therapy to treat PwCF, has resulted in increased rates of overweight and obesity, highlighting it is now prudent to establish an alternative diet for PwCF.